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Mutations in ABCB6 Cause Dyschromatosis
Universalis Hereditaria
Caie Zhang1,2,8, Duanzhuo Li3,8, Jianguo Zhang4,5,8, Xingping Chen2, Mi Huang3, Stephen Archacki6,
Yuke Tian1, Weiping Ren2, Aihua Mei2, Qingyan Zhang4, Mingyan Fang4, Zheng Su4, Ye Yin4, Dongxian Liu2,
Yingling Chen2, Xiukun Cui3, Chang Li3, Huanming Yang4, Qing Wang3, Jun Wang4,7, Mugen Liu3 and
Yunhua Deng2
Dyschromatosis universalis hereditaria (DUH) is a pigmentary genodermatosis characterized by a mixture of
hyperpigmented and hypopigmented macules distributed randomly over the body. No causative genes
have been reported to date. In this study, we investigated a large five-generation Chinese family with DUH.
After excluding the two known DUH loci, we performed genome-wide linkage analysis and identified a DUH
locus on chromosome 2q33.3-q36.1 with a maximum LOD score of 3.49 with marker D2S2382. Exome sequencing
identified a c.1067T4C (p.Leu356Pro) mutation in exon 3 of ABCB6 (ATP-binding cassette subfamily B, member 6)
in the DUH family. Two additional missense mutations, c.508A4G (p.Ser170Gly) in exon 1 and c.1736G4A
(p.Gly579Glu) in exon 12 of ABCB6, were found in two out of six patients by mutational screening using sporadic
DUH patients. Immunohistologic examination in biopsy specimens showed that ABCB6 is expressed in the
epidermis and had a diffuse cytoplasmic distribution. Examination of subcellular localization of wild-type ABCB6
in a B16 mouse melanoma cell line revealed that it is localized to the endosome-like compartment and dendrite
tips, whereas disease-causing mutations of ABCB6 resulted in its retention in the Golgi apparatus. Our studies
identified ABCB6 as the first pathogenic gene associated with DUH. These findings suggest that ABCB6 may be a
physiological factor for skin pigmentation.
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INTRODUCTION
Dyschromatosis universalis hereditaria [DUH; Online Mende-
lian Inheritance in Man (OMIM) 127500] is a rare autosomal
dominant genodermatosis initially described by Ichikawa and
Hiraga in 1933. It is characterized by asymptomatic hyperpig-
mented and hypopigmented macules that occur in a general-
ized distribution over the trunk, limbs, and sometimes the face
(Hawsawi et al., 2002; Sethuraman et al., 2002). These lesions
of irregular size and shape always appear in infancy or early
childhood (Urabe and Hori 1997; Hawsawi et al., 2002;
Sethuraman et al., 2002). The trunk and extremities are the
dominant sites containing the changes in the skin. Facial lesions
can be seen in B50% of affected individuals, but involvement
of palms and soles is unusual (Hawsawi et al., 2002). Abnor-
malities of hair and nails have also been reported (Sethuraman
et al., 2002). DUH may be associated with abnormalities
of dermal connective tissue, nerve tissue, or other systemic
complications (Hawsawi et al., 2002; Bukhari et al., 2006).
Several human genetic diseases, such as dyschromatosis
symmetrica hereditaria (DSH; OMIM 127400) and xeroderma
pigmentosum (OMIM 278700), show some overlap with
DUH. The characteristic clinical features of DSH also include
a mixture of hyperpigmented and hypopigmented macules of
various sizes, but these lesions are always limited to the dorsal
aspects of the extremities. To date, DSH and DUH have not
been found together in the same pedigree. The double-
stranded RNA-specific adenosine deaminase gene (ADAR1
or DSRAD) has been identified as the causative gene of DSH
(Miyamura et al., 2003), yet none of the ADAR1 mutations
have been identified among DUH individuals (Suzuki et al.,
2005). These results may indicate that DSH is completely
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different from DUH, although it has been suggested to be a
phenotypical variation. Xeroderma pigmentosum resembles
DUH dyschromatosis, but DUH does not show the atrophy,
xerosis, or skin cancers usually observed in xeroderma
pigmentosum patients.
DUH cases have been reported from different regions in the
world. Most published DUH pedigrees show it to have an
autosomal dominant pattern of inheritance (Xing et al., 2003;
Nuber et al., 2004), although autosomal recessive inheritance
and a few sporadic cases have been documented (Stuhrmann
et al., 2008). Two chromosome segments have been reported
to be associated with DUH: 6q24.2-q25.2 in two Chinese
families (Miyamura et al., 2003; Xing et al., 2003; Suzuki
et al., 2005) and 12q21-q23 in an Arab family (Stuhrmann
et al., 2008). No causative genes have been identified thus
far. In this study, we identified the ATP-binding cassette
transporter ABCB6 (ATP-binding cassette subfamily B,
member 6) as a pathogenic gene associated with DUH.
Three ABCB6 mutations were found in a large Chinese
DUH family, as well as in two sporadic cases of DUH.
Our investigation showed that ABCB6 is expressed in human
epidermis, and our mutations have a clinical correlation to
this skin genodermatosis.
RESULTS
Clinical features
We characterized a five-generation Chinese family with DUH,
in which the disease was transmitted in an autosomal
dominant manner (Figure 1a). The proband (V1) was a
9-year-old boy who had normal skin at birth. Hyperpigmented
and hypopigmented macules appeared initially on his trunk at
the age of 2 years, and then gradually extended to involve his
face, neck, and limbs. He did not report any pruritus or pain.
Examination of the skin showed motley hyperpigmented and
hypopigmented macules that nearly involved his whole body.
The lesions occurred in a symmetrical pattern and were most
obvious on the face, neck, trunk, and the dorsa of his hands
and feet (Figure 1b–e). His palms and soles, oral mucosa, hair,
nails, and teeth were normal, as were the rest of his physical
exam and routine blood work. Histopathological examination
of a skin biopsy from the pigmented macules showed a
pigmented basal layer of the epidermis, pigmentary incon-
tinence in the papillary dermis, and some melanophages and
lymphocytes in the upper dermis (Supplementary Figure S1
online). None of the affected members in this family were
found to have skin cancer or ocular defects, following an
ophthalmologic examination.
Linkage mapping of DUH to chromosome 2q33.3-q36.1
Genomic DNA was isolated from blood samples of patients
and unaffected family members. Linkage and haplotype
analyses were carried out to test the linkage of the family
with two known DUH loci. All individuals were genotyped
using four microsatellite markers spanning the locus on
12q21-q23 (D12S326, D12S1708, D12S351, and D12S346),
and three markers spanning the locus on 6q24.2-q25.2
(D6S1654, D6S441, and D6S1577). However, negative LOD
scores were obtained for these loci (data not shown).
After excluding the pathogenic gene in the DUH family
from two known candidate loci, a genome-wide linkage scan
using microsatellite markers was performed as described
previously (Dai et al., 2010; Wang et al., 2012a). Given the
inheritance pattern observed in our family, LOD scores
were calculated under the assumption of autosomal domi-
nant inheritance with a penetrance of 100%. Linkage and
haplotype analyses found that the disease-causative gene in
the DUH family was localized in the 2q33.3-q36.1 region,
between D2S325 and D2S126 (Figure 1a). Multipoint analysis
gave a maximum LOD score of 3.49 at D2S2382.
Exome sequencing identifies a candidate gene
We subjected the exomes of two affected (IV13 and V1) and
one unaffected (IV6) individual to exome sequencing.
Approximately 4.23 billion bases per individual were
sequenced, and 3.75 billion bases were acceptable. The mean
coverage of each sample was  59.2 (Supplementary Table S1
online). Nonsynonymous/splice acceptor and donor site/inser-
tion or deletion (NS/SS/Indel) variants were identified and
quality filtered. A variant for the disease-related pathogenic
mutation was defined as one that exclusively existed
in the two patients but appeared neither in the control of the
family nor in the databases, including dbSNP129, the 1000
Genome Project, HapMap, and YH databases (Table 1).
Twenty-nine variants remained and were located on multiple
chromosomes. Among them, only two variants in two genes
(c.1067T4C in ABCB6 and c.2584C4T in ZNF142) were
located in the 2q33.3-q36.1 region. Sanger sequencing and
cosegregation analysis showed that the c.1067T4C mutation
in exon 5 of ABCB6 occurred in all affected members, but
not in any of the unaffected individuals of the family
(Supplementary Table S2 online). The other variant,
c.2584C4T mutation in exon 8 of ZNF142, was excluded
by cosegregation analysis, and was found to be a single-
nucleotide polymorphism (SNP) in the newly released SNP
build 137 from the University of California Santa Cruz (UCSC)
Genome Browser website. The results suggest that ABCB6
may be the disease-causing mutation in DUH.
Mutation of the ABCB6 gene in DUH patients
The c.1067T4C mutation in ABCB6 leads to a proline to
leucine substitution at codon 356 (p.Leu356Pro) in the ABCB6
protein. Further direct DNA sequence analysis with a panel
of 500 unaffected control individuals matched for the
geographical location did not detect this mutation. To confirm
that ABCB6 may be the DUH disease–causing gene,
we screened all of the exons of ABCB6 in six sporadic
DUH patients by direct DNA sequence. Two additional
missense mutations, c.508A4G (p.Ser170Gly) in exon 1 and
c.1736G4A (p.Gly579Glu) in exon 12 (Figure 2a) of ABCB6,
were identified in two of these six cases. Neither of the ABCB6
mutations was found in 400 control individuals or the public
SNP databases on the 1000 Genomes Project and UCSC
Genome Browser websites. All three of the mutations
occurred in evolutionarily conserved amino acids of ABCB6
(Figure 2b). These data suggest that ABCB6 is a causative
gene for DUH.
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Figure 1. Pedigree and clinical features. (a) Pedigree and haplotype analysis. The disease haplotype is indicated by a black bar. Black symbols represent affected
individuals, and open symbols represent unaffected individuals. Circles and squares indicate female and male individuals, respectively. The arrow indicates the
proband in the family. (b–e) Clinical characteristics of the proband with dyschromatosis universalis hereditaria (DUH). The proband, a 9-year-old boy, was involved
with motley hyperpigmented and hypopigmented macules on his (b) face and neck, (d) trunk, and the (e) dorsa of hands and (c) feet in a symmetrical pattern.
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Immunohistologic staining and western blotting show ABCB6
expression in human epidermis cell
ABCB6 is reported to be widely expressed in many tissues,
with its highest expression in the heart and skeletal muscles
(Mitsuhashi et al., 2000). To examine the expression level of
ABCB6 in skin, we performed immunohistologic staining with
a polyclonal antibody against ABCB6 on normal human skin
harvested from the abdominal area. Immunohistochemical
staining of human normal skin showed that ABCB6 localized
to the epidermis and had a diffuse cytoplasmic distribution
(Figure 2c).
To confirm the ABCB6 expression in melanocytes and
keratinocytes, HaCaT (human keratinocyte line) and A375
cells (a human malignant melanoma cell line) were lysed in a
Nonidet P-40 lysis buffer. A measure of 10mg total protein was
separated via SDS-PAGE and transferred to a nitrocellulose
membrane. The membranes were probed with anti-ABCB6 or
glyceraldehyde-3-phosphate dehydrogenase antibodies. Wes-
tern blot results showed that ABCB6 was expressed in HaCaT
and A375 cells (Figure 2d).
Retention of mutant ABCB6 in the Golgi apparatus
To investigate whether the mutations of ABCB6 are associated
with DUH, we examined the subcellular localization of wild-
type and mutant ABCB6 proteins in B16 cell lines by
immunofluorescent staining. The wild-type ABCB6 and three
mutant forms of ABCB6 (p.Ser170Gly, p.Leu356Pro, and
p.Gly579Glu) were tagged with enhanced green fluorescent
protein (EGFP) fusion proteins and then transfected into mouse
B16 cells, respectively. The localization of the various fusion
proteins was determined by confocal microscopy. As
expected, wild-type ABCB6 localized to the endosome-like
compartment, and its accumulation in the dendrites could be
seen clearly (Kiss et al., 2012). At the same time, mutant
ABCB6 accumulated primarily in the perinuclear area instead
of the dendrite tips (Figure 3).
To examine the exact subcellular localization of mutant
ABCB6 in the perinuclear area, we cotransfected DsRed-
monomer-tag Golgi marker galactosyl-transferase (GalT) with
GFP-tag mutant-type or wild-type ABCB6 into B16-F1 cells.
Confocal microscopy showed that most of the mutated ABCB6
accumulated in the Golgi body instead of the dendrites,
whereas most of the wild-type ABCB6 proteins did not
colocalize to the Golgi body (Figure 3).
DISCUSSION
DUH is a heterogeneous disease. Previous studies reported
two loci responsible for DUH: 6q24.2-q25.2 and 12q21-q237
(Xing et al., 2003; Stuhrmann et al., 2008). However, no
pathogenic DUH gene has been found to date. Here we
performed an integrated approach combining linkage analysis,
whole-exome sequencing, and mutational analyses, and found
three mutations in ABCB6 in patients with DUH. Our study
identified a disease-causing gene that is responsible for DUH.
ABCB6 is an ATP-binding cassette transporter and is
reported to regulate porphyrin synthesis (Krishnamurthy
et al., 2006). It localizes to the outer mitochondrial
membrane and is a mammalian mitochondrial porphyrin
transporter. However, recent studies revealed that ABCB6 is
glycosylated in multiple cell types and is also found in the
classical secretory pathway, which includes the endoplasmic
reticulum, Golgi apparatus, plasma membrane, and exosomes
(Watabe et al., 2008; Kiss et al., 2012; Wang et al., 2012b).
DUH is considered to be attributable to a deficiency of
melanin synthesis and/or melanosome sorting (Kim et al.,
1997; Nuber et al., 2004; Wang et al., 2005). Skin pigment
melanin is synthesized by melanocytes that are located in the
basal layer of the epidermis. In melanocytes, melanin
synthesis takes place within melanosomes that are derived
from the endoplasmic reticulum. Melanosomes bud off the
Golgi complex, move to the dendrites, and are extruded into
surrounding keratinocytes (Sturm et al., 2001).
ABCB6 is reported to be present in exosomes released from
reticulocytes (Kiss et al., 2012). Exosomes are vesicles
contained in multivesicular bodies that are secreted upon
fusion of multivesicular bodies with the cell surface plasma
membrane (Simons and Raposo, 2009). Exosome secretion has
been found to relate to the melanosome transport machinery.
Table 1. Overview of all variants identified by exome sequencing in two affected (IV13 and V1) patients and one
unaffected (IV6) individual
DUH-IV6 DUH-IV13 DUH-V1
Total SNPs and indels 44,478þ 3,123 41,904þ 2,908 43,660þ 2,850
Functional SNPs and indels 7,567þ 431 7,482þ 460 7,430þ 434
Filtered_dbSNP 932þ147 977þ168 972þ163
Filtered_dbSNP_1000genomes 699þ 73 620þ 92 582þ 87
Filtered_dbSNP_1000genomes_Hapmap8 695þ 73 541þ 92 511þ 87
Filtered_dbSNP_1000genomes_Hapmap8_YH 663þ 72 533þ 91 503þ 86
Filtered_dbSNP_1000genomes_Hapmap8_YH_DUH-IV6 0 443þ 59 240þ 44
Shared by all cases 29
Within the linkage region 2 (ABCB6 and ZNF142)
Abbreviations: ABCB6, ATP-binding cassette subfamily B, member 6; dbSNP, single-nucleotide polymorphism database; DUH, dyschromatosis universalis
hereditaria; indels, insertions or deletions; SNP, single-nucleotide polymorphism.
Each cell indicates the number of candidate variants identified against different databases.
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Many melanogenic proteins are sorted in exosomes, including
Pmel17/gp100, TYRP1 (tyrosinase-related protein 1), and
MART-1 (melanoma antigen recognized by T cells) (Andre
et al., 2002; Theos et al., 2006). A recent study shows that
Rab27 functions in the exosome secretion pathway as well
(Ostrowski et al., 2010). These observations are consistent
with our examination of subcellular localization of ABCB6 in
the B16 cell line. Our finding that wild-type ABCB6 protein is
clearly expressed in the dendrites of B16 cells implies that it
may have a key role in the melanosome transport to
surrounding keratinocytes. A mutant ABCB6 protein, which
fails to localize to the dendrites, could disrupt melanosome
transport and cause DUH. Previous studies have indicated that
ABCB6 is a half-transporter (Krishnamurthy et al., 2006), and
thus mutant ABCB6 may bind to the normal type and interfere
with melanogenesis, which may explain the dominant
negative effect.
ABCB6-null mutations have been reported in humans
(Helias et al., 2012), and ABCB6 knockout mice have been
generated (Ulrich et al., 2012). No skin pigmentation disorders
have been described to date. Recently, two mutations in
ABCB6 associated with ocular coloboma have been reported
(Wang et al., 2012b). No ocular defects were found in our
DUH family or in two sporadic patients. Further studies might
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Figure 2. ABCB6 mutations cause dyschromatosis universalis hereditaria (DUH). (a) The mutations in ABCB6 and their Sanger sequencing tracing, including
c.1067T4C (p.Leu356Pro) (reverse complement), c.508A4G (p.Ser170Gly), and c.1736G4A (p.Gly579Glu). (b) The mutations in ABCB6 occurred in the
evolutionarily conserved regions. A partial sequence of ABCB6 was compared with other species orthologs. Arrows indicate the location of the three mutations
identified in DUH patients. (c) Immunohistologic staining of human skin shows that ABCB6 is localized in the basal layers of the epidermis and has a diffuse
cytoplasmic distribution. The right panel indicates a higher magnification of an insert in the left panel. Original magnifications 100 and 400. Nuclei are
counterstained with hematoxylin. (d) Western blot analysis shows the expression of ABCB6 in HaCaT and A375 cells. ABCB6, ATP-binding cassette subfamily B,
member 6; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
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reveal the relationship between the genotype of ABCB6
deficiencies and the phenotypic heterogeneity.
In conclusion, we identified the ATP-binding cassette
transporter ABCB6 as the first protein involved in DUH. With
whole-exome and Sanger sequencing in a DUH family and
two sporadic members with DUH, respectively, we identified
three mutations in the gene that encodes the ATP-binding
cassette transporter (ABCB6). We showed that ABCB6 is
expressed in the epidermis. In the mouse melanoma B16 cell
line, ABCB6 protein was distributed in an endosome-like
pattern and was rich in the dendrites. DUH disease–causing
mutations in ABCB6 caused its retention in the Golgi
body. Our findings suggest that ABCB6 may be a previously
unreported physiological factor for skin pigmentation.
Further studies on the function of ABCB6 will not only
uncover the pathogenic mechanism for DUH but will also
help us understand melanogenesis and skin pigmentation.
MATERIALS AND METHODS
Informed consent
Our study was conducted according to the Declaration of Helsinki
Principles. Written informed consent from all subjects was obtained.
The study protocol was approved by the ethics committee of Tongji
Hospital, and College of Life Science and Technology, Huazhong
University of Science and Technology.
Linkage analysis
The microsatellite markers from the Linkage Mapping Set MD-10
(Applied Biosystems, Foster City, CA) were genotyped using an ABI
3100 Genetic Analyzer. Genotypes were analyzed by the Gene
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Figure 3. Subcellular localization of wild-type and mutated ABCB6 in B16-F1 cells. Cotransfected DsRed-monomer-tag Golgi marker galactosyl-transferase (GalT)
with GFP-tag mutant-type or wild-type ABCB6 into B16-F1 cell, respectively. Golgi body is indicated by red color. Nuclei are stained with 4’,6-diamidino-2-
phenylindole (DAPI; blue color). Mutant-type or wild-type (WT) ABCB6 are indicated by enhanced green fluorescent protein (EGFP; green color). Arrows indicate
the dendrites. Scale bar¼10mm. ABCB6, ATP-binding cassette subfamily B, member 6.
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Mapper 2.5 Software program (Applied Biosystems). LOD score
was calculated with the GeneHunter 2.1 software (http://
www.mybiosoftware.com).
Exome sequencing
We obtained 15mg DNA samples from each of the three members of
the DUH family (one control and two cases) and sheared the DNA by
sonication. The sheared genomic DNA of each individual was then
hybridized with an Agilent 38M sequence capture array (Agilent
Technologies, Santa Clara, CA) to enrich the exonic DNA in each
library.
Exon-enriched DNA was sequenced by the Illumina Hiseq 2000
platform according to the manufacturer’s instructions (Illumina, San
Diego, CA). Raw image files were processed by the Illumina pipeline
for base calling and generating the reads set.
The sequencing reads were aligned to the NCBI human reference
genome (NCBI36.3) using SOAPaligner. We collected reads that were
aligned to the designed target regions for SNP identification and
subsequent analysis. The consensus sequence and quality of each
allele was calculated by SOAPsnp (http://soap.genomics.org.cn/
soapsnp.html; BGI. Shenzhen, Guangdong, China). The low-quality
variations were filtered out using the following criteria: (1) quality
score X20 (Q20); (2) average copy number at the allele site r2; (3)
distance of two adjacent SNPs X5 bp; and (4) sequencing depth X4
and r500.
Sanger sequencing
Primers used in ABCB6 variants validation and mutation analysis are
listed in Supplementary Table S2 online. PCR products from genomic
DNA were sequenced using an ABI3730XL DNA Analyzer (Interna-
tional Equipment Trading, Vernon Hills, IL). Sanger sequencing was
used to confirm the presence and identity of variants in the candidate
gene identified via exome sequencing and to screen the candidate
gene in additional sporadic cases with DUH.
Immunohistochemistry
To examine the expression of ABCB6 in skin, normal abdomen skin
samples were stained with a polyclonal antibody against ABCB6.
Formalin-fixed, paraffin-embedded wax blocks (3 mm) were cut with
a microtome (RM2016, Leica, Brunswick, Germany) and applied to
amino alkylsilane–coated slides. The sections were dried overnight at
37 1C. The slides were dewaxed and dehydrated. Heat-mediated
antigen retrieval was carried out, and endogenous peroxidase was
blocked with 0.3% hydrogen peroxide for 10 min. Staining was
carried out with the REALTM EnVisionþ /HRP RABBIT (Dako
Denmark A/S, Shanghai, China). Light microscopy was carried out with
the ordinary optics microscope (XSP-C204, COIC, Chongqing, China).
Western blot
Human HaCaT and human A375 Cells were lysed in a Nonidet P-40
lysis buffer (0.15 M NaCl, 1% NP-40, and 0.05 M Tris-HCl, pH 8.0)
treated with a mixture of protease inhibitors (0.25 mM phenylmethyl-
sulfonyl fluoride, 10 mg/ml aprotinin and leupeptin, and 1 mM
dithiothreitol). A measure of 10mg of total protein was separated
via 12% SDS-PAGE and transferred to a nitrocellulose membrane
(Whatman, London, UK). The membranes were probed with anti-
ABCB6 or glyceraldehyde-3-phosphate dehydrogenase antibodies
(Ptglab, Wuhan, China).
Construction of expression vectors
Wild-type human ABCB6 complementary DNA (Ptglab) was cloned
into the eukaryotic expression vector pEGFP-N1 (Clontech, Mountain
View, CA). Next, we performed site-directed mutagenesis to generate
the three ABCB6 mutations associated with DUH (p.Ser170Gly,
p.Leu356Pro, and p.Gly579Glu). All constructs were verified by
Sanger sequencing.
Confocal microscopy
B16-F1 cells were transfected with pEGFP-ABCB6 wild type or
mutant type. After 48 hours, cells were fixed in 4% paraformaldehyde
for 30 minutes, and then washed twice with phosphate-buffered
saline. Samples were viewed with a confocal microscope (Leica
TCS SP2 AOBS MP microscope system). Images were assembled
using Adobe Photoshop CS3 (Adobe Systems, San Jose, CA).
Internet resources
1000 Genomes (http://www.1000genomes.org/)
OMIM (http://www.ncbi.nlm.nih.gov/omim/)
UCSC Genome Browser website (http://genome.ucsc.edu/)
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